Reacta Healthcare

As NAPAAC comes to a close, we would like to thank everyone who visited the Reacta Healthcare team over the past three days. It has been a valuable opportunity to connect with industry peers who share a commitment to advancing pediatric allergy and asthma care. Events such as NAPAAC play an important role in fostering collaboration and we are grateful to have been part of it. We would like to thank Canadian Society of Allergy and Clinical Immunology for such a great event! #NAPAAC #PediatricAllergy #FoodAllergy #AllergyCare #HealthcareInnovation #ReactaHealthcare

Day 2 at Canadian Society of Allergy and Clinical Immunology. Today’s standout session challenged the idea that food allergy management should be driven by fear rather than evidence. Understanding the difference between hazard and risk, recognising patient variability and supporting informed decision-making were powerful themes throughout. #NAPAAC #FoodAllergy #Allergy #PatientCare

It’s Day 2 in Montreal at the North American Pediatric Allergy & Asthma Congress (NAPAAC) and we’re well underway with the Canadian Society of Allergy and Clinical Immunology! Great to be engaging in interesting conversations, exchanging insights, and connecting with colleagues across the pediatric allergy and asthma community. We are looking forward to the discussions still to come. #NAPAAC #PediatricAllergy #PediatricAsthma #Montreal

Today, we are pleased to share that the Reacta Healthcare Commercial Team is attending the North American Pediatric Allergy & Asthma Congress with thanks to American College of Allergy, Asthma and Immunology (ACAAI) and Canadian Society of Allergy and Clinical Immunology NAPAAC brings together leading experts and professionals dedicated to advancing pediatric allergy care. We look forward to engaging in valuable conversations around innovation, diagnostics and improving patient outcomes. If you are attending the congress, we invite you to visit us at Booth 5 to learn more about how Reacta Healthcare is supporting clinical trials globally #NAPAAC #PediatricAllergy #FoodAllergy #AllergyCare #HealthcareInnovation #ReactaHealthcare

Landed in Montreal for our first attendance at the Canadian Society of Allergy and Clinical Immunology NAPAAC. With my colleagues David Brand, Lara Marks and Andrea Emmanuel. Canadian clinical trial sites feature in many of the food allergy therapeutic trials we supply with OFC materials. I’m interested to hear more about allergy care in the Canadian healthcare system and the clinical trial capability for atopic disease. Looking forward to an interesting and productive conference.

This week, the Reacta Healthcare team will be attending the Canadian Society of Allergy and Clinical Immunology NAPAAC in Canada! Taking place from 29th to 31st of May 2026 in Montréal the Congress will bring together clinicians, researchers, and industry professionals to enable the meaningful exchange of insights and advance understanding across paediatric allergy and asthma care. Reacta Healthcare is a pharmaceutical manufacturer specialising in the development and production of standardised challenge meals for use in food allergy clinical trials. Learn more about Reacta Healthcare: https://lnkd.in/eirE5fQW

We are expanding our presence at new industry events this year as part of our ongoing growth. This week, David Brand is in Basel attending the Pharma Partnering Summit, meeting with partners across pharma and biotech. It is a great opportunity to connect with the community, share insight, and explore how we can support clinical trials.

Following Mabylon AG’s recent update, it is fantastic to be part of this clinical trial supporting research that contributes to future progress!

We are pleased to share that David Brand will be representing Reacta Healthcare today at the Pharma Partnering Summit 2026 in Basel, Switzerland!   This event brings together leaders from across the pharmaceutical sector, providing an opportunity to exchange insights, explore collaborative partnerships and stay informed on industry developments.   If you are attending, we would welcome the opportunity to connect and discuss how Reacta Healthcare supports clinical research   #PharmaPartnering #LifeSciences #ClinicalTrials #Biopharma #PharmaEvents #IndustryCollaboration #Basel #ReactaHealthcare

With just one month to go until the European Academy of Allergy and Clinical Immunology - EAACI Congress 2026, we look forward to joining the global community in Istanbul, Turkey! The EAACI event provides a vital platform for knowledge exchange, meaningful collaboration and the continued advancement of our understanding across the field. The Reacta Healthcare team will be attending and we look forward to reconnecting with colleagues, partners and new contacts across the industry. If you are attending, we would welcome the opportunity to meet. #EAACI2026 #Allergy #Immunology #ClinicalResearch #PharmaEvents #Networking